Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
INKA2 antisense RNA 1 (INKA2-AS1) is a long non-coding antisense RNA transcribed from the locus opposite the INKA2 gene on chromosome 1. Long non-coding antisense RNAs generally regulate gene expression by mechanisms including transcriptional interference, chromatin remodeling, or acting as molecular sponges for miRNAs. While INKA2-AS1’s specific functional role is not well characterized, antisense lncRNAs can affect stability, translation, or splicing of overlapping coding genes. There is currently no evidence supporting its use as a therapeutic target, biomarker, or disease-associated molecule, but research on antisense RNAs in general suggests potential regulatory functions in transcription and gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on INKA2 antisense RNA 1 (INKA2-AS1).